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A B S T R A C T   
Endoplasmic reticulum (ER) stress is an inflammatory response that contributes to endothelial cell dysfunction, a 
hallmark of cardiovascular diseases, in close interplay with oxidative stress. Recently, Sestrin2 (SESN2) emerged 
as a novel stress-inducible protein protecting cells from oxidative stress. We investigated here, for the first time, 
the impact of SESN2 suppression on oxidative stress and cell survival in human endothelial cells subjected to 
pharmacologically (thapsigargin)-induced ER stress and studied the underlying cellular pathways. We found that 
SESN2 silencing, though did not specifically induce ER stress, it aggravated the effects of thapsigargin-induced 
ER stress on oxidative stress and cell survival. This was associated with a dysregulation of Nrf-2, AMPK and 
mTORC1 signaling pathways. Furthermore, SESN2 silencing aggravated, in an additive manner, apoptosis caused 
by thapsigargin. Importantly, SESN2 silencing, unlike thapsigargin, caused a dramatic decrease in protein 
expression and phosphorylation of Akt, a critical pro-survival hub and component of the AMPK/Akt/mTORC1 
axis. Our findings suggest that patients with conditions characterized by ER stress activation, such as diabetes, 
may be at higher risk for cardiovascular complications if their endogenous ability to stimulate and/or maintain 
expression levels of SESN2 is disturbed or impaired. Therefore, identifying novel or repurposing existing phar-
macotherapies to enhance and/or maintain SESN2 expression levels would be beneficial in these conditions.   
1. Introduction 
Cardiovascular diseases driven by the epidemic prevalence of obesity 
and diabetes are placed at the pinnacle of the global mortality statistics, 
contributing to enormous social and financial burden. Reactive oxygen 
species contribute to both physiological functions and the pathogenesis 
of multiple cardiovascular disorders such as cardiomyopathies, athero-
sclerosis, stroke, and hypertension (Panth et al., 2016). Excessive reac-
tive oxygen species release can imbalance the antioxidant defense 
system leading to a state of oxidative stress that can affect the normal 
function of various key tissues and cells. Oxidative stress was shown to 
be particularly deleterious to the functions of the endothelium, a thin 
monolayer composed of endothelial cells lining the whole vasculature 
(Maamoun et al., 2019b). The endothelium plays major roles in main-
taining vascular homeostasis through the secretion of a variety of factors 
and substances, such as nitric oxide (NO) and endothelin 1, that regulate 
key processes including vasodilation and vasoconstriction, cell growth, 
angiogenesis, and fibrinolysis. Loss of proper functioning of endothelial 
cells is known as endothelial dysfunction which marks the initiating step 
towards vascular damage and atherosclerosis. It is characterized by 
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reduced NO bioavailability, weakened vascular tone, impaired angio-
genic capacity and other phenotypic changes in the endothelial cell 
lining (Abdelsalam et al., 2019; Incalza et al., 2018; Osman et al., 2020). 
Conditions leading to excessive demand for protein production in-
side the endoplasmic reticulum (ER), such as diabetes and obesity, affect 
the folding capacity of chaperone molecules residing within the ER. This 
causes the buildup of unfolded and misfolded proteins inside the ER 
lumen, causing rapidly the activation of the unfolded protein response 
(UPR). The UPR aims at restoring ER homeostasis and bringing it back to 
a resting state; however, extended activation of UPR leads to a condition 
of ER stress which promotes selective expression of stress inducible 
proteins including pro-apoptotic signaling molecules, activating tran-
scription factor (ATF)-4 and CCAAT/enhancer-binding protein (CHOP) 
(Masuda et al., 2013), and the activation of several pro-inflammatory 
signaling pathways such as c-Jun NH (2)-terminal kinase (JNK)/c-Jun 
response (Masuda et al., 2013; Panda et al., 2018). 
ER stress is closely connected to oxidative stress and dysfunction of 
endothelial cells (Maamoun et al.,2019a, 2019b; Osman et al., 2020). 
Enhanced protein synthesis within the ER causes the formation of 
excessive non-native disulfide bonds, leading to exhaustion of gluta-
thione (an antioxidant utilized to scavenge reactive oxygen species) 
which in turn increases oxidative stress (Maamoun et al., 2019a). ER 
stress also causes a loss in Ca2+ homeostasis which enhances reactive 
oxygen species production, followed by endothelial cell dysfunction 
(Carreras-Sureda et al., 2018; Gorlach et al., 2006). Conversely, an in-
crease in protein expression and enzymatic activity of ER oxidoreduc-
tase (ERO)-1α leads to excess release of hydrogen peroxide (H2O2), 
followed by ER stress activation and dysfunction of endothelial cells (Wu 
et al., 2019). Sustained ER stress increases the risk of cardiovascular 
complications by inducing an imbalance in endothelial cell functions 
(Maamoun et al.,2019a, 2019b). Reversal of ER stress was reported to 
protect against endothelial cell dysfunction by increasing endothelial 
NO synthase (eNOS) activity and improving endothelium-dependent 
vascular relaxation (Galen et al., 2012, 2014; Kassan et al., 2012). 
Several enzymatic and non-enzymatic antioxidants are known to 
scavenge free radicals and reduce oxidative stress. Among these anti-
oxidant effectors, sestrins (SESN) have attracted much interest in recent 
years. The family of SESN consists of three highly conserved member 
proteins, SESN1, SESN2 and SESN3. SESN function as stress-inducible 
metabolic regulators, protecting cells from genotoxic and oxidative 
trauma arising from DNA damage, mutations, hypoxia, starvation, and 
ER stress (Lee et al., 2012). SESN inhibit reactive oxygen species both 
directly through their enzymatic activity (redox-regulating actions) and 
by regulating specific cellular metabolic networks (Pasha et al., 2017). 
SESN regulate and contribute to the homeostasis of metabolic functions 
through the upstream regulation of the mammalian target of rapamycin 
complex 1 (mTORC1) and 5′-AMP-activated protein kinase (AMPK) 
pathways, that are crucial for nutrient sensing and energy in cells 
(Budanov and Karin, 2008; Sun et al., 2020). Of note, under stress 
conditions, SESN2 upregulation was found to enhance the degradation 
of Kelch-like ECH-associated protein 1 (Keap-1) via autophagy. In 
normal conditions, nuclear erythroid-related factor-2 (Nrf-2), an 
important transcription factor which upregulates the expression of 
multiple antioxidant genes, remains in an inactive state through binding 
to Keap-1, and hence SESN2-facilated degradation of Keap-1 leaves 
Nrf-2 active (Shin et al., 2012). 
Disruption of the SESN crosstalk networking or inactivation of SESN 
genes have major pathological implications including oxidative stress 
injury, dysfunction of mitochondria, lipid buildup, muscle decline, and 
increased risk for complications of diabetes (Lee et al., 2012; Masuda 
et al., 2013; Pasha et al., 2017). SESN2 knockdown reduced AMPK 
phosphorylation and the expression of antioxidant genes such as cata-
lase and superoxide dismutase (SOD)-2, enhanced reactive oxygen 
species release, and caused cell death in cardiomyocytes following 
treatment with lipopolysaccharide (LPS) both in vitro and in mice 
(Hwang et al., 2018). SESN2 knockdown aggravated cardiomyocyte 
hypertrophy induced by phenylephrine. However, when SESN2 protein 
was overexpressed, cardiomyocytes became protected from hypertrophy 
mediated by phenylephrine and extracellular signal-regulated kinases 
(ERK)1/2 signaling was suppressed correspondingly (Dong et al., 2017). 
The expression of all SESN family members is found to be increased in 
mouse hearts during the early stages of cardiac hypertrophy, while their 
expression significantly decreases in the late stages of cardiac hyper-
trophy and in failing rodent hearts (Liao et al., 2016). SESN2 was found 
to be induced via JNK/c-Jun pathway and offered a compensatory sur-
vival response to angiotensin II injury in human umbilical vein endo-
thelial cells (HUVEC) (Yi et al., 2014). Knockdown of SESN2 
exacerbated angiotensin II-induced oxidative stress and apoptosis (Yi 
et al., 2014). SESN2 knockdown enhanced the expression of several ER 
stress markers in LPS-exposed HUVECs (Hwang et al., 2017). The 
expression of CHOP and protein kinase RNA-like ER kinase (PERK), and 
the phosphorylation of inositol-requiring enzyme (IRE)-1α, were 
significantly increased, suggesting a role for SESN2 in endothelial cell 
survival and ER stress response (Hwang et al., 2017). Nonetheless, the 
exact role of SESN2 in regulating reactive oxygen species generation, 
cell survival and the underlying cellular mechanisms in the context of ER 
stress activation in endothelial cells, is yet to be fully understood. 
In the current study, we investigated, the impact of SESN2 suppres-
sion on oxidative stress and cell survival in human endothelial cells 
subjected to pharmacologically (thapsigargin)-induced ER stress and 
studied the underlying cellular pathways with specific focus on oxida-
tive stress and cell survival. We found that SESN2 deletion aggravated 
ER stress-induced oxidative stress and cell death through a differential 
action on autophagy, Nrf-2, AMPK/Akt/mTOR and mitogen-activated 
protein kinase (MAPK) signaling responses. 
2. Materials & methods 
2.1. Cell maintenance and treatments 
EA.hy926 endothelial cell line was acquired from the American Type 
Culture Collection (ATCC, Virginia, USA). Cells were maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM) containing low glucose 
(1 g/L) and supplemented with fetal bovine serum (FBS, 10%), L- 
glutamine (2 mM), penicillin (10,000 units) and streptomycin (10 mg/ 
L). All reagents were obtained from Gibco (ThermoScientific, Waltham, 
USA). Cells were incubated at 37 ◦C in a 95% humidified atmosphere 
saturated with 5% CO2. Only cells up to passage 20 were used in the 
experiments. 
For SESN2 gene silencing experiments, SENS2 siRNA and scrambled 
control duplexes were designed and manufactured by Integrated DNA 
Technologies (IDT, Coralville, Iowa, USA), and were used according to 
the instructions of the manufacturer. Cells were seeded into 6-well plates 
(50,000 cells/well). The second day, cells were either left untreated 
(control) or treated with scrambled or SESN2 silencing duplexes. Briefly, 
lipofectamine RNAiMAX (ThermoScientific, Waltham, USA) and du-
plexes were dissolved separately into 250 μl of OptiMEM solution each 
(ThermoScientific), and then, carefully mixed and incubated at room 
temperature for 20 min. Then, mixture was added to the wells con-
taining 2 ml of culture medium without FBS. The final concentration of 
duplexes was 10 nM. Cell culture medium was then changed after 24 h 
and cells incubated for a further 24 h (a total of 48 h post-transfection). 
Cells were then incubated in the presence or absence of thapsigargin 
(100 nM) (Invitrogen, Waltham, USA) for either 4 h or 18 h. Because 
scrambled control siRNA duplexes had no effect on SESN2 protein 
expression or cell viability (data not shown) in comparison to SESN2 
siRNA duplexes which reduced both SESN2 expression and cell viability, 
the rest of experiments were conducted using “untreated cells” as 
negative controls. 
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2.2. Western blot analysis 
After treatments, cells were carefully washed in Phosphate Buffer 
Saline (PBS) to remove excess culture medium (ThermoScientific, Wal-
tham, USA), and then total proteins were extracted using cold Radio-
immunoprecipitation Assay (RIPA) lysis buffer [0.5 M Tris pH 6.8, 20% 
Sodium dodecyl sulfate (SDS)] supplemented with a cocktail of protease 
and phosphatase inhibitors (ThermoScientific). Concentrations of pro-
teins were assessed using the bicinchoninic acid assay (Thermo-
Scientific). Equal quantities of proteins (10–20 μg) were loaded and 
separated on SDS-PAGE gels (8, 10 or 12% as appropriate for target 
molecular weights) and transferred to polyvinylidene difluoride (PVDF) 
membranes (ThermoScientific). After blocking for 1 h in tris-buffered 
saline containing 0.1% of Tween 20 (Sigma-Aldrich, Hamburg, Ger-
many) (T-TBS) supplemented with either 5% of Bovine Serum Albumin 
(BSA) (phosphorylated targets) or 5% dry milk (non-phosphorylated 
targets), the blot membranes were then washed in T-TBS and left to 
incubate with primary antibodies overnight (Pasha et al., 2019; Ravin-
dran et al., 2019). Blots were probed with the following primary anti-
bodies raised against: Binding immunoglobulin protein (BiP), CHOP, 
SESN2, p-AMPK-α (Thr172), p-mTOR (Ser2448), p-Akt (Ser473), Akt, 
p-p42/44 MAPK (Thr202/204), p42/44 MAPK, macroautophagy 
markers, light chain 3 (LC-3 I/II), p-Unc-51-like kinase (ULK)-1 
(Ser555), ULK-1 (1:1000 dilution) (Cell Signaling Technology, Danvers, 
USA), or AMPK-α1/2, Keap-1, Nrf-2 (1:1000 dilution) (Abcam, Cam-
bridge, UK) or mouse anti-β-actin (1:5000) (Santa Cruz Biotechnology, 
Dallas, USA). Blots were then washed thrice in T-TBS and incubated at 
room temperature for 1 h with appropriate horseradish 
peroxidase-conjugated secondary antibodies (1:10,000). When reprob-
ing membranes with a different antibody was required, old primary and 
secondary antibodies were stripped off using restore western blot 
stripping buffer (ThermoScientific) following the recommendations of 
the manufacturer. Briefly, PVDF membranes were incubated for 15–30 
min at 37 ◦C with stripping buffer. To visualize protein bands in a Biorad 
ChemiDoc MP imager (Biorad, Hercules, USA), enhanced chem-
iluminescence (ECL) reagent (Abcam, Cambridge, UK) was used. 
Quantification of protein band intensities was performed using image 
studio lite software (LI-COR Biosciences, Lincoln, USA). 
2.3. Total RNA isolation and gene expression analysis 
After treatments, cells were carefully washed in PBS to remove 
excess culture medium (ThermoScientific, Waltham, USA), before total 
RNA isolation and cDNA synthesis were conducted for gene expression 
studies by quantitative PCR. The innuPREP RNA kit (Analytikjena, 
Berlin, Germany) was used to extract total RNA by following the in-
structions of the manufacturer. The concentration and quality of RNA 
samples were assessed using a NanoDrop 2000 (ThermoScientific). 
Samples were then quickly transferred to − 80 ◦C until further use. The 
synthesis of cDNA was performed from total RNA (500 ng) using the 
RevertAid reverse transcription kit (ThermoScientific) and an oligo 
(dT)12-18 primer following the manufacturer’s recommendations. Using 
GoTaq qPCR Master Mix (Promega, Madison, USA), target genes were 
amplified in an Applied Biosystems QuantStudio™ 5 Real-Time PCR 
System (ThermoScientific). Melting curves were determined for all 
samples to ensure specificity of amplicons. Reference gene stability was 
determined using BestKeeper algorithm (Pfaffl et al., 2004). All exper-
iments were performed independently with five biological repeats and 3 
technical replicates, with five different passage numbers of EA.hy926 
cells. Analysis of data was performed using the ΔΔCt comparative 
method. Relative mRNA expression of target genes was normalized to 
housekeeping gene expression (β-actin) and presented as fold-change of 
negative (untreated) control group. Human primer pairs were obtained 
from Primer bank and manufactured by Integrated DNA Technologies 
(IDT, Coralville, Iowa, USA) or Sigma-Aldrich (Hamburg, Germany). 
Primer pair sequences that were used here are summarized in Table 1. 
2.4. X-box binding protein 1 (XBP-1) splicing assay 
The expression of uXBP-1 (unspliced) and sXBP-1 (spliced) tran-
scripts of XBP-1 was determined as previously described (Agouni et al., 
2011). Splicing of XBP-1 and expression of β-actin housekeeping gene 
were analyzed in cDNA from all experimental groups using innuMIX 
standard PCR masterMix (Analytikjena, Berlin, Germany). The PCR 
amplification was conducted in an Applied Biosystems ProFlex ther-
mocycler (ThermoScientific, Waltham, USA) under the following 
cycling conditions: 94 ◦C (3 min); followed by 35 cycles (94 ◦C for 10 s, 
65 ◦C for 30 s, and 72 ◦C for 30 s); and finally, 10 min at 72 ◦C. Primer 




To distinguish between uXBP-1 and sXBP-1, the products of PCR 
amplification were separated on a carefully prepared agarose gel 
(2.5%). Image studio lite software (LI-COR Biosciences, Lincoln, USA) 
was used to for the semi-quantitative analysis of band intensities. Results 
were expressed as the ratio between sXBP-1 over uXBP-1 normalized to 
the expression of β-actin housekeeping gene and presented as percentage 
(%) of untreated control. 
2.5. Cell death assessment by flow cytometry 
Cell death was quantified by flow cytometry imaging using an 
annexin V-based apoptosis kit (BD Biosciences, San Jose, USA). After cell 
transfections and treatments, as described above, supernatants were 
collected, and cells were collected with trypsin (ThermoScientific, 
Waltham, USA) and suspended in 1X annexin V binding buffer (BD 
Biosciences) (one million cells/ml). After this, cell suspensions (100 μl 
containing 100,000 cells) were mixed with annexin V (5 μl) and 
Table 1 
List of human primer pairs used in the study.  
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propidium iodide (PI) (2 μl) (BD Biosciences) and left to incubate for 30 
min while protected from light at room temperature. Cells were then 
immediately analyzed by flow cytometry using a BD LSR Fortessa system 
(BD Biosciences). Live, early apoptotic, late apoptotic and total 
apoptotic cells were expressed as a percentage of total cells counted 
(Zachariah et al., 2020). The analysis allows differentiation of 4 cell 
populations based on the staining profile with PI and annexin V: 
Annexin V negative/PI negative cells are live; Annexin V positive/PI 
negative indicate that cells are in early apoptosis stage; Annexin V 
negative/PI positive cells staining indicate cells are necrotic; Annexin V 
positive/PI positive staining indicate that cells are in late apoptosis 
stage. 
2.6. Reactive oxygen species production measurement 
Reactive oxygen species production was quantified using MitoSOX™ 
Red reagent (ThermoScientific, Waltham, USA). MitoSOX™ Red live- 
cell permeable reagent that is quickly and specifically targeted to the 
mitochondria (Dikalov and Harrison, 2014). Inside the mitochondria, 
superoxide, but not other reactive oxygen species or reactive nitrogen 
species, oxidizes MitoSOX™ Red which then emits red fluorescence. 
Following treatments, cells were suspended at a density of 1 million 
cells/ml in DMEM supplemented with MitoSOX red (5 μM) and incu-
bated for 20 min at 37 ◦C in dark. Then, cells were washed 3 times in 
warm PBS to remove excess MitoSOX™ Red. Cells were then immedi-
ately analyzed by flow cytometry using a BD LSR Fortessa system (BD 
Biosciences, San Jose, USA) for recording mean fluorescence intensity 
(MFI) and the proportion of positive cells. Results are represented as bar 
graphs representing MFI normalized to signal from control (untreated) 
cells expressed as fold change. 
2.7. Statistical analysis 
Results are expressed as mean ± standard error of mean (S.E.M.), and 
n represents the number of biological repeats. The normality of data was 
tested each time using Shapiro-Wilk normality test. Statistical analyses 
were performed with GraphPad Prism® 7.01e software for Mac using 
one-way ANOVA followed by Tukey’s multiple comparison post hoc test 
(normally distributed data) or non-parametric Kruskal-Wallis test fol-
lowed by Dunn’s multiple comparison post hoc test (not normally 
distributed data). A two-tailed P ≤ 0.05 was considered as statistically 
significant. 
3. Results 
3.1. Pharmacologically induced ER stress enhanced SESN2 protein 
expression 
As depicted in Fig. 1, exposure of cells to SESN2 siRNA duplexes 
successfully reduced SESN2 protein expression compared to untreated 
controls (Fig. 1A and B). Incubation of cells with thapsigargin (100 nM) 
for both 4 h (Fig. 1A) and 18 h (Fig. 1B) significantly increased SESN2 
protein expression, which was prevented in the presence of SESN2 
siRNA duplexes (Fig. 1A and B). 
3.2. Impact of SESN2 suppression on pharmacologically induced ER stress 
in endothelial cells 
SESN2 plays a crucial role in modulating stress conditions by acti-
vating various stress markers and metabolic pathways to achieve 
cellular homeostasis (Pasha et al., 2017). We investigated the impact of 
SESN2 silencing in EA.hy926 endothelial cells upon their exposure to 
pharmacologically-induced ER stress by thapsigargin. Thapsigargin is a 
selective inhibitor of sarcoplasmic or endoplasmic reticulum 
Ca2+-ATPase, which blocks entry of calcium into SR/ER leading to ER 
stress and eventual cell death. As shown in Fig. 2, and as expected, 
exposure of EA.hy926 cells to thapsigargin (100 nM; 4 h) caused a sig-
nificant increase in mRNA expression of all ER stress markers studied, 
namely, ATF-4, BiP, GRP94, CHOP and tribbles-related protein 3 
(TRIB3), indicating a strong activation of ER stress response. The 
silencing of SESN2 in endothelial cells caused a significant increase in 
mRNA expression of CHOP (Fig. 2D) and TRIB3 (Fig. 2E), without 
Fig. 1. Effects of SESN2 silencing and thapsigargin (TG)-mediated ER stress on SESN2 protein expression. (A, B), Western bot analysis of SESN2 protein expression, 
normalized against β-actin used as a loading control protein. Cells were left untreated or incubated with SESN2 siRNA duplexes for 48 h, and then exposed to 
thapsigargin (100 nM) for either 4 h (A) or 18 h (B). Data are presented as mean ± S.E.M. *P < 0.05, ***P < 0.001, **P < 0.01 versus CTL or versus indicated groups; 
##P < 0.01, ###P < 0.001 versus SESN2 siR. Treatment groups include CTL, control; SESN2 siR, SESN2 silenced; TG, thapsigargin; SESN2 siR + TG, SESN2 silenced 
cells treated with TG. 
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affecting other markers studied. Interestingly, when cells were chal-
lenged with thapsigargin in the presence of SESN2 siRNA duplexes, 
although an increase in mRNA expression of all the markers of ER stress 
studied was observed compared to untreated control condition, this 
increase was significantly smaller compared to thapsigargin alone 
(Fig. 2A–2E). The analysis of XBP-1 splicing revealed that the ratio of 
sXBP-1 over u-XBP-1 was higher in EA.hy926 cells exposed to thapsi-
gargin (100 nM; 4 h) compared to untreated cells and those silenced for 
SESN2 (Fig. 2F). 
As depicted in Fig. 3, the exposure of endothelial cells to thapsigargin 
for either 4 h or 18 h enhanced protein expression of ER stress molecules, 
BiP (Fig. 3A) and CHOP (Fig. 3B). Protein expression of BiP was 
significantly lower in cells silenced for SESN2 (Fig. 3A, right panel). 
Cells challenged with thapsigargin for 18 h in the presence of SESN2 
siRNA also showed a decrease in BiP protein expression compared to 
controls and thapsigargin alone group (Fig. 3A, right panel). In the 
presence of SESN2 siRNA duplexes, protein expression of CHOP in cells 
treated with thapsigargin for 4 h or 18 h was lower compared to cells 
only treated with thapsigargin; however, CHOP expression levels were 
still significantly higher compared to control condition and SESN2 
siRNA alone group (Fig. 3B). 
3.3. Effect of SESN2 suppression on reactive oxygen species production in 
endothelial cells challenged with thapsigargin 
SESN inhibit reactive oxygen species production and increase levels 
of antioxidants in cells under stress conditions (Pasha et al., 2017). The 
effect of SESN2 silencing on thapsigargin-induced ER stress with special 
emphasis on reactive oxygen species production and mRNA expression 
of NADPH oxidase subunits and key antioxidant enzymes was thus 
studied here. As shown in Fig. 4, reactive oxygen species production 
detected by MitoSOX red dye, increased by 1.6-fold in thapsigargin 
group, and 1.9-fold in SESN2 siRNA group. Interestingly, reactive oxy-
gen species production increased by 5.5-folds compared to controls in 
the concomitant presence of thapsigargin and SESN2 siRNA duplexes, 
indicating a drastic and more than additive increase in oxidative stress in 
endothelial cells deficient for SESN2 (Fig. 4). Both SESN2 deficiency and 
exposure of cells to thapsigargin increased, to the same extent, mRNA 
expression of NOX-2 (Fig. 5A), the catalytic and membrane-bound 
subunit of NADPH oxidase, and p47phox, a major regulatory subunit of 
the enzyme (Perisic et al., 2004) (Fig. 5B). 
With regards to antioxidant enzymes, SESN2 deficiency caused an 
increase in mRNA of SOD-1 compared to control and thapsigargin 
groups (Fig. 5C). Deficiency in SESN2 and exposure to thapsigargin 
caused a significant increase in mRNA expression of SOD-2 (Fig. 5D) and 
SOD-3 (Fig. 5E) compared to controls with mRNA expression of both 
SODs being higher in the presence of thapsigargin compared to SESN2 
siRNA alone group. Of note, the increase in mRNA expression of both 
SOD-1 and SOD-2 caused by thapsigargin was not affected by SESN2 
silencing (Fig. 5C and 5D). Finally, exposure of cells to thapsigargin did 
not affect mRNA expression of heme oxygenase-1 (HO-1), whereas 
SESN2 silencing caused a significant increase in its expression levels 
(Fig. 5F). 
Fig. 2. Effects of SESN2 suppression and thapsigargin (TG) on mRNA expression of various ER stress markers. Relative mRNA expression levels (fold change) of ER 
stress target markers, ATF-4 (A), BiP (B), GRP94 (C), CHOP (D), and TRIB 3 (E), normalized against β-actin housekeeping gene (n = 5 in each group). (F) Images 
represent semi-quantitative PCR quantification of sXBP-1, uXBP-1 and β-actin housekeeping gene resolved on 2.5% agarose gel. Bars represent pooled densitometry 
data normalized to β-actin and expressed as percentage (%) of untreated group (CTL) (n = 4–5 in each group). Cells were treated with SESN2 siRNA for 48 h and then 
exposed or not to thapsigargin (100 nM) for 4 h. Data are presented as mean ± S.E.M. **P < 0.01, ***P < 0.001 versus CTL or versus indicated groups; ###P < 0.001 
versus SESN2 siR. Treatment groups include CTL, control; SESN2 siR, SESN2 silenced; TG, thapsigargin; SESN2 siR + TG, SESN2 silenced cells treated with TG. 
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3.4. Effects of SESN2 suppression and thapsigargin-induced ER stress on 
the regulation of Nrf-2 signaling pathway 
Nrf-2 is an important transcriptional factor that regulates the 
expression of various antioxidant genes. SESN2 mediates its antioxidant 
effects, at least partly, via the degradation of Keap-1 through p62- 
dependent autophagy and resulting activation of Nrf-2 (23). The effect 
of SESN2 suppression and thapsigargin-induced ER stress on protein 
expression and mRNA profiling of markers of Nrf-2 pathway were thus 
investigated (Fig. 6). An increase in protein expression of Keap-1 was 
observed in cells deficient in SESN2, while a decrease was noted in cells 
exposed to thapsigargin both in the presence and absence of SESN2 
siRNA duplexes (Fig. 6A). Treatment of cells with thapsigargin on the 
other hand caused a marked increase in protein expression of Nrf-2, 
while the remaining groups showed no obvious effects compared to 
controls (Fig. 6B). Consistent with protein expression findings, at the 
mRNA expression level, an increase in the expression of Keap-1 was also 
observed in the presence of SESN2 siRNA compared to controls and 
thapsigargin alone group, whereas a decrease in Keap-1 mRNA expres-
sion was observed in cells exposed to thapsigargin alone (Fig. 6C). With 
regards to Nrf-2 downstream targets, thapsigargin caused an increase in 
mRNA expression of 6-phosphogluconate dehydrogenase (pdg) (Fig. 6D) 
and quinone oxidoreductase 1 (NQO1) (Fig. 6E); however, silencing of 
SESN2 only prevented the increase in pdg mRNA expression caused by 
thapsigargin (Fig. 6D). 
Altogether, SENS2 silencing increased reactive oxygen species pro-
duction (Fig. 4) which was associated with an overexpression of mRNA 
of antioxidant genes (SOD-1, SOD-2, SOD-3, HO-1) (Fig. 5), while the 
mRNA expression of other antioxidant genes (pdg) under the transcrip-
tional action of Nrf-2 were not affected (Fig. 6). This highlights the 
importance of Nrf-2 pathway in the dysregulation of oxidative balance 
caused by SESN2 suppression in endothelial cells. 
Fig. 3. Effects of SESN2 suppression and thapsigargin (TG) on protein expression of ER stress markers. Western blot analysis of protein expression of BiP, normalized 
against β-actin, after treatment of cells with thapsigargin (TG) for 4 h (A, left panel) or 18 h (A, right panel) in the presence or absence of SESN2 siRNA. (B), Western 
blot analysis of protein expression of CHOP, normalized against β-actin, after treatment of cells with thapsigargin (TG) for 4 h (B, left panel) or 18 h (B, right panel) in 
the presence of absence of SESN2 siRNA. Cells were treated with SESN2 siRNA for 48 h and then exposed to thapsigargin (100 nM), where specified. Representative 
images from 3 independent runs are presented. Bars represent pooled densitometry data normalized to control (CTL) (n = 3 per in each group). Data are presented as 
mean ± S.E.M. *P < 0.05, **P < 0.01, ***P < 0.001 versus CTL or versus indicated groups; ##P < 0.01 versus SESN2 siR. Treatment groups include CTL, control; 
SESN2 siR, SESN2 silenced; TG, thapsigargin; SESN2 siR + TG, SESN2 silenced cells treated with TG. 
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3.5. SESN2 silencing caused apoptosis in endothelial cells and aggravated 
pharmacological ER stress-mediated cell death 
The assessment of apoptosis by flow cytometry under conditions of 
thapsigargin-induced ER stress and SESN2 deficiency in endothelial cells 
indicated a clear role for SESN2 in endothelial cell survival in general 
and particularly under ER stress conditions (Fig. 7). As shown in Fig. 7, 
exposure of cells to thapsigargin (100 nM; 18 h) reduced the percentage 
of live cells, while increasing the percentage of early and late apoptotic 
cells; the percentage of total apoptotic cells increased from 5.6 ± 0.35% 
in controls to 32.3 ± 1.42% in thapsigargin-treated group. SESN2 
silencing alone also reduced the percentage of live cells and increased 
the proportion of early and late apoptotic cells; the percentage of total 
apoptotic cells in this group was 27.7 ± 0.65%. Interestingly, the 
exposure of cells to thapsigargin in the presence of SESN2 siRNA du-
plexes caused a dramatic reduction in the percentage of live cells and a 
staggering increase in the proportion of both early and late apoptotic 
cells, with total apoptotic cells in this group representing 60.6 ± 1.82% 
of total cell population, indicating an additive pharmacological effect 
between SENS2 silencing and thapsigargin-induced ER stress on cell 
survival in endothelial cells. 
3.6. Effects of SESN2 suppression and thapsigargin on the regulation of 
AMPK/Akt/mTORC1 axis and autophagy 
To better understand the signaling responses implicated in the effects 
of SESN2 silencing on oxidative stress and cell survival in the presence or 
absence of ER stress injury, the regulation of AMPK/Akt/mTORC1 axis 
that is involved in cell metabolism and survival was assessed. SESN2 
works in extreme co-ordination with AMPK and is essential in the 
regulation of cell growth, survival, and energy homeostasis (Pasha et al., 
2017). The effect of SESN2 silencing on the activation of AMPK was thus 
studied. SESN2 silencing markedly decreased the phosphorylation of 
AMPK at Thr172 (Fig. 8A). Exposure of cells to thapsigargin enhanced 
the phosphorylation of AMPK at Thr172, while SESN2 silencing 
completely prevented this increase (Fig. 8A). 
SESNs regulate cellular metabolic networks in close connection with 
mTORC1 signaling pathway. Excessive increase in the mTORC1 activity 
increases the risk of ER stress and consequently cellular damage, 
wherein SESN2 may come as a rescue (Sun et al., 2020). We investigated 
the activation of mTORC1 signaling pathway under conditions of 
thapsigargin-induced ER stress in the presence or absence of SESN2 
siRNA duplexes. Both SESN2 deficiency and exposure to thapsigargin 
caused an increase in the phosphorylation of mTOR (Ser2448) in 
endothelial cells (Fig. 8B). The activation of mTORC1 mediated by 
SESN2 deficiency and thapsigargin-induced ER stress was associated 
with a significant increase in the ratio between protein expression levels 
of LC3-II to LC3-I (indicating conversion of LC3-I into LC3-II), a key 
marker of macroautophagy (Fig. 8C). However, the expression of more 
specific macroautophagy markers showed a differential effect on auto-
phagy activation. The phosphorylation of Unc-51-like kinase (ULK)-1 
(Fig. 8D) and mRNA expression of Beclin-1 (Fig. 8E) were decreased in 
the presence of SESN2 siRNA duplexes. The phosphorylation of ULK-1 
was significantly enhanced in the presence of thapsigargin, an effect 
that was prevented by SESN2 silencing (Fig. 8D). 
To further harness the impact of SESN2 silencing and thapsigargin- 
Fig. 4. Effects of SESN2 suppression and thapsigargin (TG) on reactive oxygen species production. Measurement of reactive oxygen species production in EA.hy926 
endothelial cells. Following transfection with SESN2 siRNA duplexes (48 h), cells were treated overnight with thapsigargin (TG; 100 nM), and reactive oxygen species 
production was then measured by flow cytometry using mitoSOX red dye. Representative flow cytometry images of fluorescence intensity (PE/488-A) are shown for 
each experimental group. Bars represent mean fluorescence intensity (MFI) normalized to control (CTL) expressed as fold change (n = 3 per group). Data are 
presented as mean ± S.E.M. *P < 0.05, **P < 0.01, ***P < 0.001 versus CTL or versus indicated groups. Treatment groups include CTL, control; SESN2 siR, SESN2 
silenced; TG, thapsigargin; SESN2 siR + TG, SESN2 silenced cells treated with TG. 
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induced ER stress on the regulation of mTORC1 and endothelial cell 
survival, the activation of Akt was also assessed. As shown in Fig. 8F, the 
silencing of SESN2 caused a dramatic and significant decrease in protein 
expression of Akt which also drove a strong decrease in the phosphor-
ylation of Akt at Ser473, indicating a reduced activation. Exposure of 
cells to thapsigargin did not affect neither the expression nor the phos-
phorylation of Akt compared to control (Fig. 8F). This decrease in the 
expression of Akt caused by SESN2 suppression may contribute to the 
reduced survival of endothelial cells silenced for SESN2. Additionally, 
we assessed the impact of SESN2 and thapsigargin on the proliferative 
signal p42/p44 MAPK. As shown in Fig. 8G, both SESN2 silencing and 
thapsigargin enhanced the phosphorylation of p42/p44 MAPK. 
4. Discussion 
In the present study, we investigated, the impact of SESN2 suppres-
sion on oxidative stress and cell survival in endothelial cells exposed to 
pharmacologically (thapsigargin)-induced ER stress and studied the 
underlying cellular pathways. We report here that SESN2 deletion, 
though did not specifically induce a strong ER stress response, it 
aggravated thapsigargin-induced ER stress effects on reactive oxygen 
species production that was more than additive in the presence of 
thapsigargin and SESN2 silencing using specific siRNA duplexes. This 
effect was associated with a dysregulation of the antioxidant Nrf-2 
pathway and an upregulation of mRNA expression of NADPH oxidase, 
NOX-2 and p47phox, subunits. Furthermore, SESN2 deficiency aggra-
vated, in an additive manner, apoptosis caused by thapsigargin-induced 
ER stress, suggesting the activation of additional anti-survival cellular 
signals. Enhanced apoptosis caused by SESN2 silencing was associated 
with AMPK inactivation, activation of mTORC1 and enhanced activity of 
p42/44 MAPK. Importantly, we observed that SESN2 deficiency, unlike 
thapsigargin, caused a dramatic decrease in protein expression and 
phosphorylation of Akt, a key pro-survival signaling pathway, which 
may contribute to the additional effects of SESN2 silencing on reduced 
cell viability in the presence of ER stress inducer, thapsigargin. 
We observed here that the induction of ER stress caused the over-
expression of SESN2. This is in agreement with several studies that have 
reported that ER stress upregulated SESN2 in various cell types (Bruning 
et al., 2013; Ding et al., 2016; Park et al., 2014; Saveljeva et al., 2016); 
however, our study is the first to report the upregulation of SENS2 in 
endothelial cells to be directly mediated by pharmacological (thapsi-
gargin) ER stress induction. As observed in our current study, ER stress 
activation is associated with selective expression of ATF-4, which has 
been shown to directly control the mRNA expression of SESN2 (De 
Sousa-Coelho et al., 2012; Gomez-Samano et al., 2017). 
Our data indicate that SESN2 deficiency in endothelial cells did not 
dramatically affect mRNA and protein expression of key ER stress 
markers; however, prolonged exposure of cells to SESN2 siRNA duplexes 
(72 h–48 h of transfection and 18 h in the presence of thapsigargin) led 
to a decrease in protein expression of BiP and CHOP compared to con-
trols. Our findings are consistent with a previous study by Hwang et al. 
(2017) who assessed protein expression of CHOP, and phosphorylation 
of PERK and IRE-1α, as markers of ER stress. Authors reported that 
SESN2 deficiency in HUVECs did not affect the expression of these ER 
stress markers (Hwang et al., 2017). However, in our study, we observed 
that SESN2 silencing caused a reduction in mRNA (ATF-4, BiP, GRP94, 
Fig. 5. Effects of SESN2 suppression and thapsigargin (TG) on mRNA expression of prooxidant and antioxidant genes. Relative mRNA expression of NOX-2 (A), 
p47phox (B), SOD-1 (C), SOD-2 (D), SOD-3 (E), and HO-1 (F), normalized against β-actin housekeeping gene (n = 5) in cells treated with TG (100 nM) for 4 h in the 
presence or absence of SESN2 siRNA. Results are expressed as mean ± S.E.M. as fold change relative to control (CTL). *P < 0.05, **P < 0.01, ***P < 0.001 versus CTL 
or versus indicated groups; #P < 0.05, ##P < 0.01, ###P < 0.001 versus SESN2 siR + TG group. Treatment groups include CTL, control; SESN2 siR, SESN2 silenced; 
TG, thapsigargin; SESN2 siR + TG, SESN2 silenced cells treated with TG. 
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CHOP, TRIB3) and protein expression (BiP and CHOP) of all ER stress 
markers studied in cells treated with thapsigargin compared to thapsi-
gargin alone although levels were still significantly higher compared to 
control (untreated condition). This is not consistent with the observa-
tions of Hwang et al. (2018) who found that SESN2 silencing enhanced 
ER stress response caused by LPS (Hwang et al., 2018). Discrepancy may 
be explained by the mechanism of action for ER stress induction, 
depletion of Ca+2 stores for thapsigargin in our study and via interaction 
with Toll-like receptors (TLR) for LPS in the other report. 
We observed here that exposure of cells to thapsigargin stimulated 
reactive oxygen species release. Furthermore, SESN2 silencing alone 
elevated reactive oxygen species release in endothelial cells; however, 
when cells were challenged with thapsigargin in the presence of SESN2 
siRNA duplexes, reactive oxygen species production was significantly 
higher in an additive fashion. Our findings are in line with previous 
reports indicating that SESN2 deficiency leads to oxidative stress in 
endothelial cells (Hwang et al., 2018) and renal mesangial cells (Eid 
et al., 2013). However, our study further demonstrates that SESN2 
deficiency aggravates, in an additive fashion, the effects of 
pharmacologically induced ER stress on oxidative stress in endothelial 
cells, indicating overlapping molecular mechanisms between SESN2 
deficiency and thapsigargin in inducing oxidative stress. ER stress is 
intimately associated to both oxidative stress and endothelial cell 
dysfunction (Maamoun et al., 2019b). Higher demand for protein syn-
thesis within the ER lumen causes excess formation of non-native di-
sulfide bonds, which eventually exhausts intracellular stores of 
glutathione and subsequent oxidative stress (Maamoun et al., 2019a). 
ER stress disrupts Ca2+ homeostasis enhancing thus reactive oxygen 
species release (Carreras-Sureda et al., 2018; Gorlach et al., 2006). 
Conversely, during ER stress response, the activity of ERO-1α is also 
increased leading to excess H2O2 (Wu et al., 2019). The antioxidant 
actions of SESN2, though not fully understood, can be mediated by 
inhibiting reactive oxygen species both directly through their enzymatic 
activity (redox-regulating actions) and by regulating specific cellular 
metabolic networks (Pasha et al., 2017). SESN regulate and contribute to 
the homeostasis of metabolic functions through upstream regulation of 
mTORC1 and AMPK pathways, that are crucial for nutrient sensing and 
energy in cells (Budanov and Karin, 2008; Sun et al., 2020). SESN2 
Fig. 6. Effects of SESN2 suppression and thapsigargin (TG) on the activation of Nrf-2 pathway. (A, B), western blot analysis showing protein expression levels of 
Keap-1 (A) and Nrf-2 (B) normalized against β-actin loading control. Bars represent pooled densitometry data normalized to total amount of β-actin expressed as 
percentage of control (% of CTL) (n = 3 in each group). Data are presented as mean ± S.E.M. (C–E), Relative mRNA expression, expressed as fold change relative to 
control (CTL), of Keap-1 (C), Pdg (D), and NQO1 (E) normalized against β-actin housekeeping gene (n = 5 per group). Data are presented as mean ± S.E.M. *P < 0.05, 
**P < 0.01, ***P < 0.001 versus CTL or indicated groups; #P < 0.05, ##P < 0.05, ###P < 0.001 versus SESN2 siR group. Treatment groups include CTL, control; SESN2 
siR, SESN2 silenced; TG, thapsigargin; SESN2 siR + TG, SESN2 silenced cells treated with TG. 
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upregulation enhances the degradation of Keap-1 via autophagy under 
stress states, which directs Nrf-2 for degradation (Shin et al., 2012). We 
report here that increased reactive oxygen species production caused by 
both SESN2 deficiency or thapsigargin in endothelial cells was associ-
ated with an increase in mRNA expression of NOX-2 and its regulatory 
subunit p47phox in addition to SOD-2 and SOD-3; however, SOD-1 and 
HO-1 were only increased in cells deficient for SESN2. This differential 
expression in antioxidant enzymes between cells treated with thapsi-
gargin in the presence or absence of SESN2 siRNA, indicate overlapping 
pro-oxidant cellular mechanisms, further explaining the additive effects 
on reactive oxygen species production observed with concomitant 
SESN2 silencing and thapsigargin-induced ER stress. Our data corrobo-
rate our previous observations that thapsigargin-induced ER stress is 
associated with elevated reactive oxygen species production in endo-
thelial cells and enhanced activity of NADPH oxidase (phosphorylated 
p47phox) (Maamoun et al., 2017). In the current study, we also uncover a 
differential action between thapsigargin-induced ER stress and SESN2 
deficiency in regulating Nrf-2 pathway. While thapsigargin reduced the 
expression Keap-1 and enhanced Nrf-2 expression and its downstream 
targets (NQO-1 and Pdg), the silencing of SESN2 in endothelial cells 
caused a decrease in the expression of Keap-1, indicating a lower acti-
vation of Nrf-2 in SESN2-silenced cells. Despite its documented role in 
the antioxidant actions of SESN2, our study is the first to show that Nrf-2 
activation is reduced in endothelial cells deficient for SESN2. In accor-
dance with previous studies, including in endothelial cells (Hwang et al., 
2017, 2018), we showed here that SESN2 deletion caused a reduction in 
the phosphorylation of AMPK; however, we also extend our observation 
to an increase in the activation of mTORC1 pathway and subsequent 
inhibition of autophagy, both of which have been linked to the antiox-
idant actions of SESN2 (Pasha et al., 2017). Interestingly, 
thapsigargin-induced ER stress was associated with enhanced phos-
phorylation of AMPK, prevented by SESN2 deletion, and activation of 
mTORC1 and autophagy, further highlighting the discrepancy in 
mechanisms mediated by SESN2 deficiency and thapsigargin, contrib-
uting to the additive pharmacological effects on oxidative stress and 
apoptosis. 
In agreement with a previous report (Hwang et al., 2018), we found 
here that SESN2 deletion increased the percentage of apoptotic 
endothelial cells. Furthermore, and in line with our previous report 
(Maamoun et al., 2017), we also found that thapsigargin-induced ER 
stress caused an increase in apoptosis. Of particular interest, we show 
here that SESN2 silencing caused an additive apoptotic effect in endo-
thelial cells exposed to thapsigargin, suggesting the activation of 
non-overlapping apoptotic mechanisms in the presence of both condi-
tions, which may further contribute to the additive effect on oxidative 
stress observed in these cells. Several mechanisms may contribute to this 
situation. First, the inactivation of AMPK was shown to contribute to cell 
death mediated by SESN2 deficiency (Pasha et al., 2017). Furthermore, 
the activation of mTORC1 and subsequent inhibition of autophagy in 
cells deficient for SESN2 may also contribute to enhanced apoptotic 
signals. The inhibition of mTORC1 has been shown to prevent low shear 
stress-induced apoptosis and oxidative stress in endothelial cells by 
preventing downregulation of SESN1 (Zhang et al., 2014). One focal 
observation in our current study is the downregulation of Akt protein 
expression, and subsequent reduction in its phosphorylation and hence 
activation, in endothelial cells deficient for SESN2 compared to controls 
and cells treated only with thapsigargin. This is a novel finding which 
may explain the additive apoptotic effect of SESN2 deletion in 
thapsigargin-treated cells because of the well-documented endothelial 
pro-survival role of Akt (Gerber et al., 1998; Shiojima and Walsh, 2002). 
Akt is a major signaling hub for the regulation of metabolism and cell 
survival and its activation is intimately associated with the regulation of 
AMPK and mTORC1 pathways. In addition, Akt is a critical regulator of 
endothelial cell function and mediates the activation of eNOS and in-
creases NO production in endothelial cells (Dimmeler et al., 1999). 
Moreover, the overexpression of TRIB3 associated with SESN2 defi-
ciency and thapsigargin treatment may further contribute to the inac-
tivation of Akt (Du et al., 2003). An increase in the activation of p42/44 
MAPK pathway was observed in cells exposed to both thapsigargin and 
SESN2 siRNA. As a proliferative pathway, this may be a compensatory 
mechanism to overcome the loss of activity of Akt and strong activation 
of apoptotic signals. 
Taken together, these data suggest that although SESN2 silencing per 
se did not cause a strong increase in ER stress response and did not 
potentiate the expression of key ER stress markers caused by thapsi-
gargin, it did aggravate the consequences of ER stress response induction 
Fig. 7. Effects of SESN2 suppression and thapsigargin 
(TG) on endothelial cell death. Assessment of 
apoptosis by flow cytometry using Annexin V and PI 
staining (n = 3 per group) in EA.hy926 cells left un-
treated (CTL) or incubated with TG (100 nM; over-
night) in the presence or absence of SESN2 siRNA 
duplexes (after 48 h of transfection). Bars represent 
pooled data expressed as percentage of live cells, 
early apoptotic cells, late apoptotic cells, and total 
apoptotic cells in each group. Representative flow 
cytometry images of fluorescence intensity are shown 
for each experimental group. Data are presented as 
mean ± S.E.M. **P < 0.01, ***P < 0.001 versus CTL 
or indicated groups; ##P < 0.05, ###P < 0.001 versus 
TG group. The groups include untreated cells or 
control (CTL); SESN2 siR, SESN2 silenced cells; TG, 
thapsigargin-treated cells (100 nM; overnight); SESN2 
siR + TG, SESN2 silenced cells treated with TG.   
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in endothelial cells. This inflammatory pathway is intimately associated 
with several metabolic and cardiovascular pathologies and is involved in 
the pathogenesis of endothelial dysfunction (Maamoun et al., 2019a). 
5. Conclusion 
These data suggest that patients with disease conditions character-
ized by the activation of ER stress response are at higher risk for car-
diovascular complications if their endogenous capacity to increase and/ 
or maintain expression levels SESN2 is not optimal. In line with this, it 
has recently been reported that mRNA SESN2 levels are significantly 
reduced in patients suffering from dyslipidemia, and diabetes with and 
without dyslipidemia (Sundararajan et al., 2020). Therefore, identifying 
novel or repurposing existing pharmacological strategies (e.g., metfor-
min) to enhance or maintain the expression levels of SESN2 would be 
beneficial in pathological states associated with sustained ER stress 
activation such as diabetes, obesity, or atherosclerosis. 
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